The long-range goals of this project are to understand the biochemistry and biology of antigen presentation by class II MHC molecules. The project centers on the presentation of peptides from the protein hen-egg white lysozyme (HEL). The investigator's laboratory has extensive experience studying HEL and a large technical armamentarium for this purpose. The study is primarily based on analysis of the dominant peptide from HEL selected by I-Ak (=Ak) molecules of antigen presenting cells, during intracellular HEL processing. The features that make the 48-62 peptide dominant (=DGSTDYGILQINSRW) have been identified. These include a robust anchor residue (D52) and main chain interactions between the peptide and residues in the Ak peptide-combining site. Using this information, how changes in the anchor residue of the peptide influence a number of binding parameters and immunogenicity will be analyzed. Analysis of APC bearing 48-62 tethered to the Akb chain is included. Based on this information, HEL molecules bearing changes in the main anchor position will be engineered and will be examined both in cell lines, and in transgenic mice expressing HEL in their APC, for the expression of dominant, and sub-dominant peptides. These peptides will be examined biochemically, including the use of new approaches for identifying minor epitopes. This manipulation will inform us whether dominant peptides control the expression of other HEL peptides. The experiments will be extended using transgenic mice expressing HEL in their APC as a transmembrane protein. These experiments should make it possible to examine how the display of major epitopes influence immunological and tolerogenic parameters. The strength of this goal is that it is based on a combination of biochemical and immunological parameters. The last goal is to examine different conformational states of peptide-MHC class II complexes that are relevant for T cell recognition. T cells that recognize peptides derived from HEL processing (type A); and unique ones that exclusively recognize MHC-peptide complexes formed by direct binding of peptide (type B) have been identified. These distinct types of recognition are important to understand because of their relevance for vaccination, autoimmunity and processing. In brief, the goal is to interpret and point out the significance of the biochemical parameters that underlie peptide-MHC interactions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI024742-15
Application #
6373113
Study Section
Allergy and Immunology Study Section (ALY)
Program Officer
Deckhut Augustine, Alison M
Project Start
1987-05-01
Project End
2002-04-30
Budget Start
2001-05-01
Budget End
2002-04-30
Support Year
15
Fiscal Year
2001
Total Cost
$588,577
Indirect Cost
Name
Washington University
Department
Pathology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Calderon, Boris; Carrero, Javier A; Unanue, Emil R (2014) The central role of antigen presentation in islets of Langerhans in autoimmune diabetes. Curr Opin Immunol 26:32-40
Nayak, Deepak K; Calderon, Boris; Vomund, Anthony N et al. (2014) ZnT8-reactive T cells are weakly pathogenic in NOD mice but can participate in diabetes under inflammatory conditions. Diabetes 63:3438-48
Mohan, James F; Unanue, Emil R (2013) A novel pathway of presentation by class II-MHC molecules involving peptides or denatured proteins important in autoimmunity. Mol Immunol 55:166-8
Mohan, James F; Calderon, Boris; Anderson, Mark S et al. (2013) Pathogenic CD4? T cells recognizing an unstable peptide of insulin are directly recruited into islets bypassing local lymph nodes. J Exp Med 210:2403-14
Carrero, Javier A; Calderon, Boris; Towfic, Fadi et al. (2013) Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse. PLoS One 8:e59701
Yang, Chiao-Wen; Unanue, Emil R (2013) Neutrophils control the magnitude and spread of the immune response in a thromboxane A2-mediated process. J Exp Med 210:375-87
Ireland, Jamie M; Unanue, Emil R (2012) Processing of proteins in autophagy vesicles of antigen-presenting cells generates citrullinated peptides recognized by the immune system. Autophagy 8:429-30
Calderon, Boris; Unanue, Emil R (2012) Antigen presentation events in autoimmune diabetes. Curr Opin Immunol 24:119-28
Strong, Beverly S I; Unanue, Emil R (2011) Presentation of type B peptide-MHC complexes from hen egg white lysozyme by TLR ligands and type I IFNs independent of H2-DM regulation. J Immunol 187:2193-201
Ireland, Jamie M; Unanue, Emil R (2011) Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells. J Exp Med 208:2625-32

Showing the most recent 10 out of 20 publications